| Targeting Wee1 kinase as a therapeutic approach in Hematological Malignancies S Vakili-Samiani, AT Jalil, WK Abdelbasset, AV Yumashev, V Karpisheh, ... DNA repair 107, 103203, 2021 | 105 | 2021 |
| The molecular mechanisms and therapeutic potential of EZH2 in breast cancer S Adibfar, M Elveny, HS Kashikova, MV Mikhailova, P Farhangnia, ... Life sciences 286, 120047, 2021 | 20 | 2021 |
| The molecular biology and therapeutic potential of Nrf2 in leukemia A Khodakarami, S Adibfar, V Karpisheh, S Abolhasani, P Jalali, ... Cancer Cell International 22 (1), 241, 2022 | 19 | 2022 |
| Increased susceptibility to doxorubicin-induced cell death in acute lymphocytic leukemia cells by inhibiting serine/threonine WEE1 kinase expression using the chitosan … AAH Feizi, S Vakili-Samiani, V Karpisheh, A Masjedi, S Izadi, S Adibfar, ... Journal of Drug Delivery Science and Technology 77, 103868, 2022 | 6 | 2022 |
| Combined inhibition of EZH2 and CD73 molecules by folic acid-conjugated SPION-TMC nanocarriers loaded with siRNA molecules prevents TNBC progression and restores anti-tumor … S Adibfar, A Masjedi, A Nazer, B Rashidi, V Karpisheh, S Izadi, ... Life sciences 309, 121008, 2022 | 4 | 2022 |
Farhad Jadidi-NiaraghTabriz University of Medical Sciences在 tbzmed.ac.ir 的电子邮件经过验证
